Featured Jobs
|
Relationship Manager - Defined Contributions Daybright Financial
|
|
Client Service Executive: Employee Benefits Consulting Global Employee Benefits Consulting Firm
|
|
Plan Document Support Specialist ASC Actuarial Systems Corporation
|
|
BLG PLLC
|
|
Heritage Pension Advisors, Inc.
|
|
Daybright Financial
|
Free Publications
|
|
ASPE Analysis of New Generic Markets Effect of Market Entry on Generic Drug Prices: Medicare Data 2007-2022 (PDF)
Assistant Secretary for Planning and Evaluation [ASPE], U.S. Department of Health and Human Services [HHS] 
Jan. 17, 2025 "In 2022, it was estimated that 91% of all prescriptions in the United States were filled as generic drugs.... Generic drug prices are consistently lower than brand-name prices across all market sizes and time periods ... The impact of competition on relative drug prices is stable over time: the price reductions are similar for generic drugs first entering the market in the most recent period 2016-2019 compared to both earlier periods, 2007-11 and 2012-15." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |